investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Molecular Studies of Cellular Cytotoxicity
Stephen Anderson
3 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Colin Brooks
Newcastle University
Newcastle upon Tyne, United Kingdom
Yenan Bryceson
Karolinska Institute
Stockholm, Sweden
Andrew Makrigiannis
University of Ottawa
Ottawa, Canada
Stephen Anderson
National Cancer Institute (NIH)
Rockville, United States
Related projects
Alan Anderson
Inducible metabolism of xenochemicals and endogenous toxic compounds: Nuclear receptors and the CYP2B paradigm
All cancers but non-melanoma skin cancer
Investigator from Uppsala University
Organ-specific mechanisms of lymphatic vascular development and specialisation
All cancers but non-melanoma skin cancer
Peter J Burke
High-throughput on-chip platform for interrogation of mitochondrial membrane potential and apoptosis
All cancers but non-melanoma skin cancer
Marc Nicklaus
Fundamentals of Ligand-Protein Interactions
All cancers but non-melanoma skin cancer
Carl Hansen
A high-throughput single-cell technology for the function-based discovery of monoclonal antibody antagonists of G-protein coupled receptors in cancer
All cancers but non-melanoma skin cancer
Till Bartke
Molecular Mechanisms of Chromatin Regulation by DNA and Histone Modifications and Epigenetic Reader Molecules
All cancers but non-melanoma skin cancer
Huiyan Zeng
Targeting orphan nuclear receptor TR3/Nur77 for tumor angiogenesis
All cancers but non-melanoma skin cancer
Stephen Hughes
Integrase
All cancers but non-melanoma skin cancer
William G. Dunphy
Control of Cell Cycle Transitions
All cancers but non-melanoma skin cancer